NuVasive

$68.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+0.12%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, and ETFs commission-free!

About NUVA

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring.

CEO
J. Christopher Barry
Employees
2,700
Headquarters
San Diego, California
Founded
1997
Market Cap
3.48B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
586.82K
High Today
$69.50
Low Today
$68.29
Open Price
$68.52
Volume
545.94K
52 Week High
$69.50
52 Week Low
$43.11

NUVA Earnings

-$0.52
-$0.10
$0.31
$0.73
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

ADIL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure